Intensity Therapeutics

Intensity Therapeutics EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intensity Therapeutics (INTS) as of Oct 20, 2026 is -11.97 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -16.59 M USD — a change of -27.81% (higher).

EBITDA

-11.97 MUSD

YoY

-27.81%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intensity Therapeutics is 2025 -11.97 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intensity Therapeutics was 2024 -16.59 M USD. It decreases by -27.81% higher compared to the previous year.

The Intensity Therapeutics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-5.68 M USD
Jan 1, 2020
-6.22 M USD
Jan 1, 2021
-8.01 M USD
Jan 1, 2022
-7.50 M USD
Jan 1, 2023
-8.32 M USD
Jan 1, 2024
-16.59 M USD
Jan 1, 2025
-11.97 M USD
The Intensity Therapeutics EBITDA history
YEAREBITDAYoY
-11.97 MUSD-27.81%
-16.59 MUSD+99.36%
-8.32 MUSD+10.88%
-7.50 MUSD-6.38%
-8.01 MUSD+28.77%
-6.22 MUSD+9.65%
-5.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Intensity Therapeutics Stock analysis

What does Intensity Therapeutics do? Intensity Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intensity Therapeutics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intensity Therapeutics is -11.97 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intensity Therapeutics changed from -16.59 M USD to -11.97 M USD, representing a -27.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Intensity Therapeutics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Intensity Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Intensity Therapeutics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Intensity Therapeutics